Costs and resource use of community-dwelling patients with Alzheimer’s disease in Japan: 18-month results from the GERAS-J study

Author:

Nakanishi Miharu1ORCID,Igarashi Ataru23,Ueda Kaname4ORCID,Brnabic Alan J. M.5,Matsumura Taka4,Meguro Kenichi67,Yamada Masahito8ORCID,Mimura Masaru9,Arai Heii10,Treuer Tamas11

Affiliation:

1. Research Center for Social Science and Medicine Tokyo Metropolitan. Institute of Medical Science, Tokyo, Japan

2. Department of Health Economics and Outcomes Research Graduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo, Japan

3. Yokohama City University, Yokohama, Japan

4. Eli Lilly Japan K.K, Kobe, Japan

5. Eli Lilly Australia Pty, Limited, West Ryde, Sydney, Australia

6. Geriatric Behavioral Neurology Project, New Industry Creation Hatchery Center, and Division of Nuclear Medicine, Cyclotron Radioisotope Center, Tohoku University, Sendai, Japan

7. Osaki-Tajiri SKIP Center, Osaki, Japan

8. Department of Neurology and Neurobiology of Aging, Graduate School of Medical Sciences, Kanazawa University, Kanazawa, Japan

9. Department of Neuropsychiatry, School of Medicine, Keio University, Tokyo, Japan

10. ALZCLINIC TOKYO, Tokyo, Japan

11. Eli Lilly and Company, Budapest, Hungary

Publisher

Informa UK Limited

Subject

General Medicine

Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3